Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging

Liselotte Højgaard; Anne Kiil Berthelsen; Annika Loft

doi:10.1016/j.cpet.2013.11.002

Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging

PET Clin. 2014 Apr;9(2):141-5. doi: 10.1016/j.cpet.2013.11.002.

Authors

Liselotte Højgaard¹, Anne Kiil Berthelsen², Annika Loft²

Affiliations

¹ Department of Clinical Physiology, Nuclear Medicine & PET, Faculty of Health and Medical Sciences, Rigshospitalet, University of Copenhagen, KF 4011, Blegdamsvej 9, DK 2100, Copenhagen, Denmark. Electronic address: lottepet@rh.dk.
² Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, KF 4011, Blegdamsvej 9, DK 2100, Copenhagen, Denmark.

PMID: 25030278
DOI: 10.1016/j.cpet.2013.11.002

Abstract

Positron emission tomography (PET)/computed tomography with FDG of the head and neck region is mainly used for the diagnosis of head and neck cancer, for staging, treatment evaluation, relapse, and planning of surgery and radio therapy. This article is a practical guide of imaging techniques, including a detailed protocol for FDG PET in head and neck imaging, physiologic findings, and pitfalls in selected case stories.

Keywords: Benign tumors; Computed tomography; Head and neck; Imaging; Physiologic uptake; Positron emission tomography.

Publication types

Review

MeSH terms

Artifacts
Fasting
Fluorodeoxyglucose F18* / pharmacokinetics
Head and Neck Neoplasms / diagnostic imaging*
Humans
Multimodal Imaging / methods*
Patient Positioning
Positron-Emission Tomography / methods*
Positron-Emission Tomography / standards
Radiation Dosage
Radiopharmaceuticals* / pharmacokinetics
Tomography, X-Ray Computed / methods*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18